SCHEMBL7187955

SCHEMBL7187955

CCCOc1c(/C=C/C(=O)c2ccc(O)cc2)cc(C(C)(C)CC)c(O)c1C(C)(C)CC

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 5/20 0.49
PTPN1 P18031 3/20 0.44
DPP4 P27487 4/20 0.43
IDH1 O75874 1/20 0.43
ABCB1 P08183 1/20 0.43
UGT1A1 P22309 1/20 0.43
ABCC1 P33527 1/20 0.43
PRMT6 Q96LA8 1/20 0.43
CAPN1 P07384 1/20 0.41
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CYP1A1 P04798 2/20 0.41
CYP1B1 Q16678 2/20 0.41
MAOB P27338 3/20 0.41
CHRNA7 P36544 1/20 0.40
P4HB P07237 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7187960 1.00 ABCG2 (0.49) ABCG2PTPN1DPP4IDH1ABCB1
SCHEMBL7192360 0.92 CTSL (0.42) ABCG2PTPN1DPP4IDH1ABCB1
SCHEMBL7192357 0.92 CTSL (0.42) ABCG2PTPN1DPP4IDH1ABCB1
SCHEMBL7186737 0.92 ABCG2 (0.47) ABCG2PTPN1DPP4IDH1ABCB1
SCHEMBL7186733 0.92 ABCG2 (0.47) ABCG2PTPN1DPP4IDH1ABCB1
SCHEMBL7185690 0.90 DPP4 (0.39) ABCG2PTPN1DPP4IDH1ABCB1
SCHEMBL7185684 0.90 DPP4 (0.39) ABCG2PTPN1DPP4IDH1ABCB1
SCHEMBL7796224 0.89 PTPN1 (0.51) ABCG2PTPN1DPP4IDH1ABCB1
SCHEMBL7796220 0.89 PTPN1 (0.51) ABCG2PTPN1DPP4IDH1ABCB1
SCHEMBL7184229 0.88 ABCG2 (0.54) ABCG2PTPN1DPP4IDH1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed